GlassScriptPhysician profile
Tiffany Trowles
NPI 1578028239
$3,550.87
in general payments reported to CMS, 2019-2025
19 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,911 · 2022: $1,350 · 2023: $64.15 · 2024: $105 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $773.33 | 2021-2023 | |
| Alkermes, INC. | $575.34 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $414.64 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $354.34 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $291.81 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $237.82 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $225.77 | 2024-2025 | Uzedy |
| Vanda Pharmaceuticals INC. | $198.76 | 2021-2022 | |
| Indivior INC. | $132.59 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $109.07 | 2021-2023 | Rexulti |
| Merck Sharp & Dohme LLC | $56.29 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $31.64 | 2022 | |
| Noven Therapeutics, LLC | $26.64 | 2021 | |
| Supernus Pharmaceuticals, INC. | $25.94 | 2022 | |
| Janssen Pharmaceuticals, INC | $22.92 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $21.73 | 2021 | |
| Lundbeck LLC | $17.70 | 2021 | |
| Adlon Therapeutics L.P. | $17.30 | 2021 | |
| Eisai INC. | $17.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Trowles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.